Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 7, 2007, Pages 1373-1379

  Pouplard, C ^a   Gueret, P ^a   Fouassier, M ^b   Ternisien, C ^b   Trossaert, M ^c   Regina S ^d   Gruel, Yves ^a,d,e  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^{b *}

^c INSERM U618 ^*  (France)

^d INSERM   (France)

^e SERVICE DE DERMATOLOGIE   (France)

Author keywords

4Ts score; Heparin; Particle gel immunoassay; Thrombocytopenia

Indexed keywords

DANAPAROID; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC TEST; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOASSAY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RELIABILITY; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROTONIN RELEASE; THROMBOSIS;

EID: 34250767666     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02524.x     Document Type: Article

References (31)

1. Chong BH. Heparin-induced thrombocytopenia. J Thromb Haemost 2003; 1: 1471-8.
2. Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost 2005; 94: 132-5.
3. Warkentin TE. Heparin-induced thrombocytopenia: Pathogenesis and management. Br J Haematol 2003; 121: 535-55.
4. Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse B, Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14 serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clinical Pathol 1999; 111: 700-6.
5. Keeling D, Davidson S, Watson H. The management of heparin-induced thrombocytopenia. Br J Haematol 2006; 133: 259-69.
6. Warkentin T, Levine M, Hirsh J, Horsewood P, Roberts R, Gent M, Kelton J. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Eng J Med 1995; 332: 1330-5.
7. Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need? J Lab Clin Med 2005; 146: 341-6.
8. Pouplard C, May MA, Regina S, Marchand M, Fusciardi J, Gruel Y. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol 2005; 128: 837-41.
9. Warkentin TE. Laboratory testing for heparin-induced thrombocytopenia. J Thromb Thrombolysis 2000; 10 (Suppl. 1): 35-45.
10. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation testfor the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993; 69: 344-50.
11. Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytopenia. Chest 2005; 2 (Suppl.): 35S-45S.
12. Eichler P, Budde U, Haas S, Kroll H, Loreth R, Meyer O, Pachmann U, Potzsch B, Schabel A, Albrecht D, Greinacher A. First workshop for detection of heparin-induced antibodies: Validation of heparin-induced platelet activation test (HPIA) in comparison with PF4/heparin ELISA. Thromb Haemost 1999; 81: 625-9.
13. Tardy B, Lecompte T, Boelhen F, Tardy-Poncet B, Elalamy I, Morange P, Gruel Y, Wolf M, Francois D, Racadot E, Camarasa P, Blouch MT, Nguyen F, Doubine S, Dutrillaux F, Alhenc-Gelas M, Martin-Toutain I, Bauters A, Ffrench P, de Maistre E, et.al. Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood 2006; 108: 1492-6.
14. Lubenow N, Greinacher A. Drugs for the prevention and treatment of thrombosis in patientwith heparin-induced thrombocytopenia. Am J Cardiovasc Drugs 2001; 1: 429-43.
15. Alberio L, Kimmerle S, Baumann A, Taleghani BM, Biasiutti FD, Lammle B. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia. Am J Med 2003; 114: 528-36.
16. Eichler P, Raschke R, Lubenow N, Meyer O, Schwind P, Greinacher A. The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays. Br J Haematol 2002; 116: 887-91.
17. Pouplard C, Amiral J, Borg JY, Vissac AM, Delahousse B, Gruel Y. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium. Br J Haematol 1997; 99: 273-80.
18. Sheridan D, Carter C, Kelton J. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 27-30.
19. Fagan TJ. Letter: Nomogram for Bayes theorem. N Engl J Med 1975; 293: 257.
20. Sackett D, Strauss S, Richardson W, Rosenberg W, Haynes R. Evidence-Based Medicine: How to practice and teach EBM, 2nd edn. Edinburgh: Churchill Livingstone, 2000: 67-93.
21. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4: 759-65.
22. Gruel Y, Pouplard C, Nguyen P, Borg JY, Derlon A, Juhan-Vague I, Regnault V, Samama M. Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia. Br J Haematol 2003; 121: 786-92.
23. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005; 106: 2710-5.
24. Deeks JJ, Altman DG. Diagnostic tests 4: Likelihood ratios. BMJ 2004; 329: 168-9.
25. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005; 365: 1500-5.
26. Lindhoff-Last E, Eichler P, Stein M, Plagemann J, Gerdsen F, Wagner R, Ehrly AM, Bauersachs R. A prospective study on the incidence and clinical relevance of heparin- induced antibodies in patients after vascular surgery. Thromb Res 2000; 97: 387-93.
27. Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Eur J Haematol 2006; 76: 420-6.
28. Pouplard C, May MA, Iochmann S, Amiral J, Vissac AM, Marchand M, Gruel Y. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: Clinical implications for heparin-induced thrombocytopenia. Circulation 1999; 99: 2530-6.
29. Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003; 2: 148-57.
30. Alberio L, Lammle B. More on: Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2005; 3: 1549.
31. Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2004; 2: 2133-7.